WallStSmart
VALN

Valneva SE ADR

NASDAQ: VALN · HEALTHCARE · BIOTECHNOLOGY

$5.38
+0.94% today

Updated 2026-04-30

Market cap
$480.43M
P/E ratio
P/S ratio
2.75x
EPS (TTM)
$-1.59
Dividend yield
52W range
$5 – $12
Volume
0.1M

Valneva SE ADR (VALN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-2.73M$-3.56M$-1.84M$939000.00$-3.15M$-8.66M$-13.22M$-20.90M$-14.94M$-24.33M$6.50M$12.83M$16.31M$5.53M$137.74M$76.90M$-245.34M$-202.74M$-67.22M$-52.89M
Capital expenditures$1.15M$1.13M$1.31M$4.14M$5.64M$8.12M$822000.00$3.27M$3.74M$2.65M$3.68M$4.04M$3.17M$10.88M$19.47M$93.17M$29.32M$14.31M$16.44M$4.48M
Depreciation
Stock-based comp$936000.00$588000.00$539000.00$234000.00$179000.00$530000.00$1.02M$1.43M$811000.00$1.89M$2.55M$6.33M$14.51M$-8.66M$5.11M$7.97M$9.53M
Free cash flow$-3.88M$-4.70M$-3.15M$-3.20M$-8.79M$-16.77M$-14.04M$-24.18M$-18.68M$-26.98M$2.82M$8.79M$13.13M$-5.36M$118.27M$-16.27M$-274.67M$-217.06M$-83.66M$-57.38M
Investing cash flow
Financing cash flow
Dividends paid$27.65M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash